We are live on ! Find out more
Capital Research Global Investors

Capital Research Global Investors Portfolio holdings

AUM $717B
1-Year Est. Return 35.42%
 

Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+35.42%
3 Year Est. Return
+133.7%
5 Year Est. Return
+183.13%
10 Year Est. Return
+734.77%
AUM
$315B
AUM Growth
-$456M
Cap. Flow
-$7.8B
Cap. Flow %
-2.48%
Top 10 Hldgs %
27.58%
Holding
443
New
29
Increased
207
Reduced
136
Closed
42

Top Buys

Rank Stock Value
1
STZ icon
Constellation Brands
STZ
+$1.47B
2
TRP icon
TC Energy
TRP
+$1.44B
3
AVGO icon
Broadcom
AVGO
+$1.37B
4
ALC icon
Alcon
ALC
+$1.22B
5
UNH icon
UnitedHealth
UNH
+$1.02B

Sector Composition

Rank Sector Weight
1 Healthcare 19.37%
2 Technology 16.98%
3 Consumer Discretionary 12.52%
4 Communication Services 11.95%
5 Industrials 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRUP icon
301
Trupanion
TRUP
$1.33B
$57.7M 0.02%
1,595,694
+191,500
+14% +$6.29M
CCI.PRA
302
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
$57.5M 0.02%
47,811
+11
+0% +$13K
MOH icon
303
Molina Healthcare
MOH
$10.7B
$57.3M 0.02%
400,317
-2,201,313
-85% -$302M
MTB icon
304
M&T Bank
MTB
$36.8B
$56.7M 0.02%
333,600
MMYT icon
305
MakeMyTrip
MMYT
$5.63B
$56.4M 0.02%
2,273,058
-5,786
-0.3% -$146K
PEGA icon
306
Pegasystems
PEGA
$5.27B
$54.8M 0.02%
+1,540,000
New +$54.8M
EIGI
307
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$54.3M 0.02%
11,304,955
+320,600
+3% +$1.74M
COUP
308
DELISTED
Coupa Software Incorporated
COUP
$53.6M 0.02%
423,120
-110,880
-21% -$11.9M
GH icon
309
Guardant Health
GH
$22B
$53.5M 0.02%
+620,299
New +$47.4M
STT icon
310
State Street
STT
$52.3B
$53.3M 0.02%
951,628
+582
+0.1% +$36.2K
KREF
311
KKR Real Estate Finance Trust
KREF
$496M
$50.6M 0.02%
2,542,300
CGNX icon
312
Cognex
CGNX
$10.3B
$50.4M 0.02%
1,050,000
MSI icon
313
Motorola Solutions
MSI
$76.8B
$50M 0.02%
300,000
GOOS
314
Canada Goose Holdings
GOOS
$850M
$49.9M 0.02%
1,289,654
+235,154
+22% +$10.6M
PPG icon
315
PPG Industries
PPG
$25.6B
$49.5M 0.02%
424,383
-1,762,841
-81% -$201M
FISV
316
Fiserv Inc
FISV
$28.1B
$48.9M 0.02%
536,700
BRSL
317
Brightstar Lottery PLC
BRSL
$2.19B
$48.2M 0.02%
+3,713,000
New +$50.5M
ACIA
318
DELISTED
Acacia Communications Inc
ACIA
$48M 0.02%
1,018,556
-108,807
-10% -$5.72M
SWN
319
DELISTED
Southwestern Energy Company
SWN
$47.9M 0.02%
15,165,596
+6,085
+0% +$23.6K
SLAB icon
320
Silicon Laboratories
SLAB
$7.31B
$47.9M 0.02%
463,000
TWO
321
Two Harbors Investment
TWO
$1.27B
$47.5M 0.02%
+936,505
New +$49.2M
EMR icon
322
Emerson Electric
EMR
$89.6B
$45.5M 0.01%
682,465
+615
+0.1% +$41.2K
PRMW
323
DELISTED
Primo Water Corporation
PRMW
$45.4M 0.01%
3,693,557
+1,536,175
+71% +$20.7M
CHK
324
DELISTED
Chesapeake Energy Corporation
CHK
$45.1M 0.01%
115,696
+105
+0.1% +$52.5K
XLNX
325
DELISTED
Xilinx Inc
XLNX
$44.2M 0.01%
375,000
-177,000
-32% -$20.6M

Similar funds

Capital Research Global Investors's Q2 2019 Portfolio in Review

As of Q2 2019, Capital Research Global Investors held 443 positions worth $315B, down 0.14% from $315B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Capital Research Global Investors's Q2 2019 filing shows 29 new, 207 increased, 136 reduced and 42 closed positions. Its largest new stake was TC Energy: 30,064,463 shares worth $1.49B. The largest sale was AbbVie, an estimated $2.86B.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Capital Research Global Investors's largest Q2 2019 buy was TC Energy: 30,064,463 shares worth $1.49B.
  • Capital Research Global Investors added most to Constellation Brands in Q2 2019, an estimated $1.47B increase.
  • Capital Research Global Investors's biggest Q2 2019 reduction was AbbVie, cutting an estimated $2.86B.
  • Capital Research Global Investors fully exited Johnson Controls International in Q2 2019, selling an estimated $403M.
  • Capital Research Global Investors's ten largest holdings make up 28% of its $315B portfolio in Q2 2019.
  • Capital Research Global Investors opened 29 new positions and closed 42 in Q2 2019.
  • Capital Research Global Investors's portfolio value fell 0.14% quarter-over-quarter to $315B.

Based on Capital Research Global Investors's 13F filing for Q2 2019, filed 14 Aug 2019.